Target Names |
Adiponectin (ACRP30), AgRP, Angiopoietin-2, Amphiregulin, Axl, bFGF, beta-NGF, Betacellulin (BTC), CCL28 (MEC), CTACK (CCL27), Dtk, EGFR, ENA-78 (CXCL5), Fas (TNFRSF6/Apo-1), FGF-4, FGF-9, GCSF, GITR Ligand (TNFSF18), GITR (TNFRSF18), GRO alpha/beta/gamma, GRO alpha (CXCL1), HCC-4 (CCL16), HGF, ICAM-1 (CD54), ICAM-3 (CD50), IGFBP-3, IGFBP-6, IGF-1 R, IL-1 R4 (ST2), IL-1 R1, IL-11, IL-12 p40, IL-12 p70, IL-17A, IL-2 R alpha, IL-6 R, IL-8 (CXCL8), I-TAC (CXCL11), Lymphotactin (XCL1), MIF, MIP-1 alpha (CCL3), MIP-1 beta (CCL4), MIP-3 beta (CCL19), MSP alpha/beta, NT-4, Osteoprotegerin (TNFRSF11B), Oncostatin M, PLGF, gp130, TNF RII (TNFRSF1B), TNF RI (TNFRSF1A), TECK (CCL25), TIMP-1, TIMP-2, Thrombopoietin (TPO), TRAIL R3 (TNFRSF10C), TRAIL R4 (TNFRSF10D), uPAR, VEGF-A, VEGF-D |
Targets Detected |
ACRP30, Adiponectin, AgRP, Amphiregulin, Angiopoietin-2, Apo-1, AXL, beta-NGF, Betacellulin, bFGF, BTC, CCL16, CCL19, CCL25, CCL27, CCL28, CCL3, CCL4, CD50, CD54, CTACK, CXCL1, CXCL11, CXCL5, CXCL8, Dtk, EGFR, ENA-78, ErbB1, Fas, FGF-4, FGF-9, G-CSF, GITR, GITR Ligand, gp130, GRO, GRO alpha, HCC-4, HGF, I-TAC, ICAM-1, ICAM-3, IGF-1 R, IGFBP-3, IGFBP-6, IL-1 R1, IL-1 R4, IL-11, IL-12 p40, IL-12 p70, IL-17, IL-2 R alpha, IL-6 R, IL-8, Lymphotactin, MEC, MIF, MIP-1 alpha, MIP-1 beta, MIP-3 beta, MSP alpha/beta, NT-4, Oncostatin M, Osteoprotegerin, PlGF, ST2, TECK, Thrombopoietin, TIMP-1, TIMP-2, TNF RI, TNF RII, TNFRSF10D, TNFRSF11B, TNFRSF18, TNFRSF6, TNFSF18, TPO, TRAIL R3, TRAIL R4, uPAR, VEGF-A, VEGF-D, XCL1 |
Citation |
1. Brunt KR., et al. Ex Vivo Akt/HO-1 Gene Therapy to Human Endothelial Progenitor Cells Enhances Myocardial Infarction Recovery. Cell Transplant. 2012, 21(7):1443-61. 2. Brunt KR., et al. Ex Vivo Akt/HO-1 Gene Therapy to Human Endothelial Progenitor Cells Enhances Myocardial Infarction Recovery. Cell Transplant. 2012, 21(7):1443-61. 3. Duncan JA, Gao X, Huang MT-H, O'Connor BP, Thomas CE, et al. Neisseria gonorrhoeae Activates the Proteinase Cathepsin B to Mediate the Signaling Activities of the NLRP3 and ASC-Containing Inflammasome. J Immunol. 2009, 182:6460-6469. 4. Ye Z, Lich JD, Moore CB, Duncan JA, Williams KL, Ting JP-Y. ATP Binding by Monarch-1/NLRP12 Is Critical for Its Inhibitory Function. Mol Cell Biol. 2008, 28:1841–1850. 5. Kocaoemer A, Kern S, Kluter H, Bieback K, Human AB Serum and Thrombin-Activated Platelet-Rich Plasma Are Suitable Alternatives to Fetal Calf Serum for the Expansion of Mesenchymal Stem Cells from Adipose Tissue. Stem Cell. 2007, 25:1270–1278. 6. Nolting T., et al. Measurement of soluble inflammatory mediators in cerebrospinal fluid of human immunodeficiency virus–positive patients at distinct stages of infection by solid-phase protein array. J Neurovirol. 2009 Sep, 15(5-6):390-400. doi: 10.3109/13550280903350192. 7. Nolting T., et al. Measurement of soluble inflammatory mediators in cerebrospinal fluid of human immunodeficiency virus–positive patients at distinct stages of infection by solid-phase protein array. J Neurovirol. 2009 Sep, 15(5-6):390-400. doi: 10.3109/13550280903350192. 8. Yang C.Q., MCP-1 Stimulates MMP-9 Expression via ERK 1/2 and p38 MAPK Signaling Pathways in Human Aortic Smooth Muscle Cells. Cell Physiol Biochem 2014, 34:266-276 DOI: 10.1159/000362997 9. Park JE., Hypoxic Tumor Cell Modulates Its Microenvironment to Enhance Angiogenic and Metastatic Potential by Secretion of Proteins and Exosomes. Molecular & Cellular Proteomics, June 1, 9, 1085-1099. |